GNLN:NASDAQGreenlane Holdings, Inc. Analysis
Data as of 2026-05-19 - not real-time
$3.61
Latest Price
9/10Risk
Risk Level: High
Executive Summary
The stock trades at $3.61, just above the computed support of $3.60 and well below the 20‑day SMA of $4.54, indicating limited upside in the near term. Technicals show a bearish MACD (line below signal) and a neutral trend with RSI at 42, suggesting neither oversold nor overbought conditions. Volume is decreasing and beta is nearly 3, amplifying the 232% 30‑day volatility and pointing to a highly speculative price action. Fundamental metrics are distressed: revenue plunged 70%, operating margin is –12.4%, and EPS is deeply negative, while the price‑to‑book ratio of 0.03 implies the market values the company at a fraction of its book value.
Despite the weak operating results, the DCF model estimates a fair value of $27, implying a >600% upside from current levels, and the firm has recently regained Nasdaq compliance and is pursuing a digital‑asset treasury strategy that could unlock new revenue streams. However, regulatory exposure in both tobacco and crypto, the absence of any dividend, and a market cap of only $2.3 M heighten liquidity and sector risks. Investors should weigh the speculative upside against the extreme volatility and near‑zero earnings before taking a position.
Despite the weak operating results, the DCF model estimates a fair value of $27, implying a >600% upside from current levels, and the firm has recently regained Nasdaq compliance and is pursuing a digital‑asset treasury strategy that could unlock new revenue streams. However, regulatory exposure in both tobacco and crypto, the absence of any dividend, and a market cap of only $2.3 M heighten liquidity and sector risks. Investors should weigh the speculative upside against the extreme volatility and near‑zero earnings before taking a position.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- Price hovering at support with bearish MACD
- Extreme 30‑day volatility and high beta
- Decreasing volume indicating waning buying interest
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Regained Nasdaq compliance reduces immediate delisting risk
- Potential upside from digital‑asset strategy
- Continued earnings deficits and weak cash flow
Long Term
> 3 yearsPositive
Model confidence: 4/10
Key Factors
- DCF fair value suggests >600% upside
- Low price‑to‑book ratio indicating deep discount to assets
- Strategic pivot to blockchain could create new revenue streams
Key Metrics & Analysis
Financial Health
Revenue Growth-69.50%
P/E Ratio-0.7
ROE-272.88%
ROA-71.83%
P/B Ratio0.0
Op. Cash Flow$-17645000
Free Cash Flow$289.1K
Technical Analysis
TrendNeutral
RSI41.8
Support$3.60
Resistance$7.06
MA 20$4.54
MA 50$4.48
MA 200$17.13
MACDBearish
VolumeDecreasing
Fear & Greed Index89.61
Valuation
Fair Value$27.11
GradeUndervalued
TypeValue
Risk Assessment
Beta2.94
Volatility232.48%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.